General
Mounjaro (Tirzepatide)
Virtual visit

Mounjaro (Tirzepatide)

Get Mounjaro (tirzepatide) online from a licensed provider. Targets two hormones for superior weight loss. Same-day prescriptions sent to your pharmacy.

The first new class of diabetes medication introduced in nearly a decade, with greater blood sugar control compared to all other treatments tested.

Dual GIP/GLP-1 activation delivers greater blood sugar reductions and weight loss than single-receptor GLP-1 therapies

Prescribed only if appropriate for patients (aged 10 and older) with type 2 diabetes, with ongoing medical support

Visit options

Costs shown are for the visit only. You'll pay for medication at your preferred pharmacy.

Video Visit

$25

Est. or $100 w/o insurance

Chat Visit

$30

w/o insurance

Most insurance accepted

Board-certified

No hidden fees

Available nationwide

What is Mounjaro®?

Mounjaro® activates both GIP and GLP-1 receptors simultaneously—making it a different type of diabetes medication than traditional GLP-1 therapies like Ozempic®. It's why Mounjaro® consistently outperformed alternatives in clinical trials.

Mounjaro® is an incredibly powerful diabetes medication. While it shares the same active ingredient (tirzepatide) as Zepbound®, it is specifically FDA-approved for adults with type 2 diabetes to improve glycemic control.

Taken once weekly, Mounjaro® works by activating the body's receptors to stimulate insulin production, suppress glucagon release, slow gastric emptying, and reduce appetite. Most patients start at a lower initiation dose and increase to a higher maintenance dose based on their blood sugar response and tolerance.

Delivers superior blood sugar control

by activating both GIP and GLP-1 receptors, which work together to stimulate insulin release when blood sugar is elevated and reduce glucagon secretion—resulting in consistently better A1C reductions.

Slows gastric emptying

to prevent post-meal blood sugar spikes and promote a feeling of fullness that can support weight management as an important secondary benefit for patients with type 2 diabetes.

Reduces appetite and food intake

by activating receptors in areas of the brain important for appetite regulation and reducing food noise.

Improves insulin sensitivity

and helps your body use glucose more effectively, reducing the amount of sugar your liver produces and helping your muscles take up more glucose from the bloodstream.

Virtual visit with clinician

Ongoing support, always available.

You’ll be treated by experts with years of experience in managing weight, metabolic health, and related conditions such as hypertension and insulin resistance.

Our clinicians will monitor progress. If medication is prescribed, we will adjust dosing and manage side effects safely. If lab testing is ordered, we review results and refine your plan accordingly. You’re never left navigating alone.

Mounjaro (Tirzepatide)

How Mounjaro® can change your day-to-day

Blood sugar control that actually works

Many patients describe reaching blood sugar targets they never thought possible—with 91% of participants in a key trial achieving an A1C of 7% or lower, and 43% achieving an A1C of 5.7% or lower.

Weight loss as a powerful secondary benefit

Patients treated with Mounjaro® lost between 12 and 25 pounds on average in trials—meaningful weight reduction that can improve overall metabolic health.

Confidence in a medication that outperforms the competition

With Mounjaro, you can rest assured that you're on a therapy that has been proven to reduce blood sugar.

With General Medicine, weight loss is a part of your long-term care plan.

Whether you want access to a GLP-1 or a more comprehensive approach, you’ll always start with an expert clinician. They evaluate your full health history, lifestyle, and past weight-loss attempts to build a plan designed for long-term health.

Your care plan
Clinician
1

Share your health story

Complete a brief medical questionnaire so our clinicians can understand your goals, history, and unique challenges.

2

Meet your clinician

Book a virtual weight-loss visit with a licensed physician who evaluates your needs and determines if medication is right for you. It’s covered by insurance.

3

Get your care plan

If eligible, your clinician will prescribe the most appropriate treatment—GLP-1 or non-GLP-1. They’ll also help you manage related conditions such as hypertension or metabolic syndrome.

4

Start seeing results

Track your progress, schedule follow-up visits anytime, and adjust your treatment as your body evolves.

Clinical outcomes and care2.4%
Mounjaro® delivered superior blood sugar reduction versus all other treatments in clinical trials. Participants achieved an average 1.8% to 2.4% reduction in A1C depending on dose and starting point.

In a study against semaglutide, Mounjaro® demonstrated significantly better A1C reductions – meaning more patients achieved their blood sugar goals.

While not indicated for weight loss, participants treated with Mounjaro® lost between 12 lbs and 25 lbs on average across studies.

What our customers have to say

Hear from people who felt heard, understood, and supported on General Medicine's weight loss program

“General Medicine helped me accomplish what I couldn't do alone, and was always there if I had a question.”

Melinda

“With regular checkups and consistent guidance, I was able to improve my blood pressure, maintain healthier blood sugar levels, and build better daily habits around nutrition and exercise. Having ongoing support and preventive care made it easier to stay accountable and make steady progress toward a healthier lifestyle.”

Brandy

“It was so simple to access the care that I needed to improve my health and life.”

Brandon

“I love the easy access and flexible appointments. The communication and how they always check in for you is a big thing.”

Waldo

Start improving your metabolic health today.

Frequently asked questions about Mounjaro®

How is Mounjaro® different from Zepbound® or other GLP-1 medications?

Mounjaro® and Zepbound® contain the same active ingredient (tirzepatide), but they have different FDA-approved indications. Mounjaro® is specifically approved for adults and children (10 years and older) with type 2 diabetes to improve blood sugar control. Zepbound® is approved for chronic weight management in adults with obesity or overweight—regardless of whether they have diabetes. If you have type 2 diabetes, Mounjaro® is the appropriate choice. If you're seeking weight loss without diabetes, Zepbound® may be more appropriate.

Mounjaro® also differs from single-receptor GLP-1 medications like Ozempic® (semaglutide) because it activates both GIP and GLP-1 receptors, which has resulted in greater A1C reductions in clinical trials.

How long does it take to work?

Blood sugar improvements often begin within the first few weeks of treatment. Most patients see meaningful A1C reductions within 8–12 weeks, with some patients reaching an A1C target of ≤7% as early as 8 weeks and ≤6.5% by 12 weeks. Significant weight loss can occur as early as 28 weeks.

Can I switch to a different diabetes medication later?

Yes. Your General Medicine clinician will stay involved and can discuss switching to another medication if your needs or goals change—whether that's a different GLP-1 like Ozempic®, an oral option like Rybelsus®, or adjusting your overall diabetes management plan.

Is Mounjaro® safe long-term?

Mounjaro® has been studied in clinical trials ranging from 40 to 52 weeks with a well-characterized safety profile. Long-term use should always be supervised by a clinician who can monitor your blood sugar, A1C, weight, and overall metabolic health and adjust treatment as needed.

Will insurance cover Mounjaro®?

Most Medicare Part D plans and commercial insurance plans cover Mounjaro® for adults with type 2 diabetes, though prior authorization is commonly required. Eligible commercially insured patients may pay as little as $25 per month with Eli Lilly's savings card (up to $1,950 in annual savings). Medicare/Medicaid patients cannot use manufacturer savings cards but may qualify for Medicare Extra Help or other assistance programs. Our team can help you navigate your insurance coverage.

What are common side effects?

The most common side effects of Mounjaro® are typically mild to moderate, occur most often during dose escalation, and tend to improve over time. They may include: nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, abdominal pain.

More serious but less common risks include pancreatitis, changes in vision, low blood sugar , kidney problems, and gallbladder problems. Mounjaro® should not be used in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

Logo

© 2026 Path Healthcare Systems Corp.